Related Experiment Video

Updated: Dec 4, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Quality of Life in Children With Diabetes Treated With Insulin Pump Compared With Multiple Daily Injections in

Adnan Al Shaikh1, Abdullah M Al Zahrani1, Yousef H Qari1

  • 1King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

Clinical Medicine Insights. Endocrinology and Diabetes
|October 22, 2020
PubMed

Insights

Continuous Subcutaneous Insulin Infusion (CSII) offers better quality of life for children with type 1 diabetes compared to Multiple Daily Injections (MDI), despite increased worry. This study compares glycemic control and well-being in pediatric diabetes management.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Management
  • Quality of Life Research

Background:

  • Type 1 diabetes in children requires effective management strategies like Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Injections (MDI).
  • Quality of Life (QoL) is a critical, yet underexplored, aspect of pediatric diabetes care, impacting psychological and physical well-being.
  • Previous research indicates insufficient evidence regarding the impact of insulin pump therapy on health-related QoL in children.

Purpose of the Study:

  • To evaluate and compare the health-related quality of life (QoL) in pediatric patients with type 1 diabetes using CSII versus MDI.
  • To assess the psychological impacts associated with CSII and MDI treatment modalities in children with diabetes.

Main Methods:

  • A cross-sectional study involving 68 pediatric patients with type 1 diabetes (T1DM).
  • Participants were treated at a tertiary center in Jeddah, Saudi Arabia.
  • Health-related QoL was measured using the Pediatric Quality of Life Inventory 3.0 Diabetes Module.

Main Results:

  • The study included 34 patients on MDI and 34 patients on CSII.
  • CSII users reported significantly better symptom control and fewer treatment difficulties.
  • However, CSII participants also exhibited higher levels of worry compared to MDI users.

Conclusions:

  • The Continuous Subcutaneous Insulin Infusion (CSII) group demonstrated superior quality of life across most domains, despite experiencing greater anxiety.
  • Further research with larger sample sizes is recommended for broader generalizations on CSII versus MDI in pediatric diabetes.
Abstract

Keywords:
Health related Quality Of Lifechildrendiabetes mellitusinsulin pumpmultiple daily injections

More Related Videos

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

7.8K
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice11:10

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice

Published on: November 16, 2011

95.4K

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
513
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
523
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
753
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.8K